I’d like to shear this news from Parkinson’s News Today:
The U.S. Food and Drug Administration in December 2023 cleared the device for measuring brain electrical activity and selectively destroying damaged nervous tissue during functional neurosurgery, or surgery to restore neuronal function. NeuroOne said at the time it expected to launch the system in the first half of 2024.